Redwood Pharma (REDW) | Spotlight

Redwood Pharma is a pharmaceutical company. The main focus is on the production of ophthalmic pharmaceuticals. The products contain active substances that are used in the treatment of dry eye disease (DED), characterised by dryness, pain, and burning. The disorder is caused by inflammation due to dysfunction of the glands as well as by the usage of contact lenses. The company is based in Stockholm.

Quotes for Redwood Pharma AB

Right Now

+/-: 0.48
%: 9,06%
Latest: 5.78
High: 5.84
Low: 5.42
Volume: 28 311
Turnover (SEK): 160 740
Value (MSEK): 72,2

Board

CEO

Martin Vidaeus

Chairman Of The Board

Gunnar Mattsson

Board

Hans Ageland
Ingrid Atteryd-Heiman
Martin Vidaeus
Mats Lidgard

News

2019-04-16 08:06:33 Årsredovisning 2018
2019-04-05 08:17:16 Kallelse till årsstämma i Redwood Pharma AB
2019-03-18 08:58:38 Styrelseledamoten Bengt Furberg avliden
2019-02-13 09:44:25 Redwood Pharma AB (publ) Bokslutskommuniké 2018
2019-02-11 08:32:23 Redwood Pharma to Attend BIO-Europe 2019, Mar. 25 - 27 in Vienna for Partnering Discussions

Show More

News agencies

2019-04-05 08:34:33 Finwire: Redwood Pharmas styrelse föreslås till omval
2019-03-18 09:05:35 Finwire: Redwood Pharmas styrelseledamot Bengt Furberg avliden
2019-02-13 09:53:56 Finwire: Redwood Pharma rapporterar som väntat ingen omsättning men minskar förlusten under fjärde kvartalet
2019-02-04 08:08:16 Direkt: FÖRSTA PATIENT BEHANDLAS I FAS 2
2019-02-04 08:07:13 Finwire: Redwood Pharma rekryterar första patienten till fas II-studie med RP101

Show More

Videos

Upcoming reports

2019-05-07 Delårsrapport 2019-Q1
2019-05-07 Årsstämma 2018
2019-08-30 Delårsrapport 2019-Q2
2019-11-19 Delårsrapport 2019-Q3
2020-02-14 Bokslutskommuniké 2019

Annual reports, prospectus etc.